Owner Rigel Pharmaceuticals, Inc.

Inventors Darwish, Ihab; Thota, Sambiah; Markovtosov, Vadim; Yu, Jiaxin; Ding, Pingyu; Atuegbu, Andy; Argade, Ankush; Bhamidipati, Somasekhar; Clough, Jeffrey; Singh, Rajinder; Hong, Hui

Agent Davies Collison Cave

Pub. Number AU-A-2009214440

PCT Pub. Number WO2009/103032

Priority 61/112,046 06.11.08 US; 61/038,672 21.03.08 US; 61/029,265 15.02.08 US

Filing date 13 February 2009

Wipo publication date 20 August 2009

C07D 451/00 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 451/04 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 491/08 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or